Ibio Inc Share Price Today: Live Updates & Key Insights

Ibio Inc share price today is $2.1201, up -0.48%. The stock opened at $2.09 against the previous close of $2.1, with an intraday high of $2.14 and low of $2.005.

Ibio Inc Share Price Chart

Ibio Inc

us-stock
To Invest in {{usstockname}}
us-stock

Ibio Inc Share Price Performance

$2.1201 -0.0048(-0.48%) IBIO at 23 Mar 2026 01:33 PM Biotechnology
Lowest Today 2.005
Highest Today 2.14
Today’s Open 2.09
Prev. Close 2.1
52 Week High 4.86
52 Week Low 0.56
Day’s Range: Low 2.005 High 2.14
52-Week Range: Low 0.56 High 4.86
1 day return -
1 Week return -11.34
1 month return -14.05
3 month return +5.23
6 month return +162.4
1 year return -54.91
3 year return -94.92
5 year return -99.75
10 year return -

Ibio Inc Institutional Holdings

Ibio Inc Market Status

Strong Buy: 3

Buy: 0

Hold: 0

Sell: 0

Strong Sell: 0

Ibio Inc Fundamentals

Market Cap 72.20 M

PB Ratio 1.2826

PE Ratio 0.0

Enterprise Value 22.81 M

Total Assets 23.19 M

Volume 1206427

Ibio Inc Company Financials

Annual Revenue FY25:400000 0.4M, FY24:225000 0.2M, FY23:50000 0.1M, FY22:2383000 2.4M, FY21:2371000 2.4M

Annual Profit FY25:400000 0.4M, FY24:225000 0.2M, FY23:50000 0.1M, FY22:2167000 2.2M, FY21:909000 0.9M

Annual Net worth FY25:-18377000 -18.4M, FY24:-24907000 -24.9M, FY23:-29311000 -29.3M, FY22:-51005000 -51.0M, FY21:-23259000 -23.3M

Quarterly Revenue Q4/2025:0 0.0M, Q3/2025:100000 0.1M, Q2/2025:200000 0.2M, Q1/2025:0 0.0M, Q4/2024:200000 0.2M

Quarterly Profit Q4/2025:-241000 -0.2M, Q3/2025:-189000 -0.2M, Q2/2025:200000 0.2M, Q1/2025:null 0.0M, Q4/2024:200000 0.2M

Quarterly Net worth Q4/2025:-8993000 -9.0M, Q3/2025:-5720000 -5.7M, Q2/2025:-5163000 -5.2M, Q1/2025:-4861000 -4.9M, Q4/2024:-4364000 -4.4M

About Ibio Inc & investment objective

Company Information iBio, Inc., a preclinical stage biotechnology company, engages in the development of artificial intelligence (AI) antibodies solutions for cardiometabolic and obesity space. The company's technology platforms include EngageTx that provides improved CD3 T-cell engager antibody panel; ShieldTx, an antibody masking technology that enables the creation of conditionally activated antibodies; StableHu, an AI antibody-optimizing technology; and AI epitope steering technology that guides antibodies against the desired regions of the target protein. Its product pipelines for cardiometabolic disease area include IBIO-101, an anti-CD25 Mab that binds and depletes immunosuppressive regulatory treg cells to inhibit the growth of solid tumors; CCR8, an antibody that enhance the body's immune response against cancer cells; and MUC16 antibodies. In addition, the company is developing EGFRvIII, an antibody therapeutics that targets EGFRvIII protein with the aim to address these cancer types without affecting healthy cells; and TROP-2 x CD3 bispecific antibody that is developed with EngageTx platform to harness T cells to kill TROP-2"expressing tumors while minimizing the cytokine release that often limits the tolerability of T-cell engagers. It has a collaboration agreement with AstralBio to discover and develop novel antibodies for obesity and other cardiometabolic diseases. The company was formerly known as iBioPharma, Inc. and changed its name to iBio, Inc. in August 2009. iBio, Inc. was incorporated in 2008 and is headquartered in San Diego, California.

Organisation Biotechnology

Employees 20

Industry Biotechnology

CEO Dr. Martin B. Brenner D.V.M., Ph.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Ibio Inc FAQs

What is the share price of Ibio Inc today?

The current share price of Ibio Inc is $2.1201.

Can I buy Ibio Inc shares in India?

Yes, Indian investors can buy Ibio Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Ibio Inc shares in India?

You can easily invest in Ibio Inc shares from India by:

Can I buy fractional shares of Ibio Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Ibio Inc?

Ibio Inc has a market cap of $72.20 M.

In which sector does Ibio Inc belong?

Ibio Inc operates in the Biotechnology sector.

What documents are required to invest in Ibio Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Ibio Inc?

The PE ratio of Ibio Inc is N/A and the PB ratio is 1.28.